We are live on ! Find out more

1,762 hedge funds and large institutions have $119B invested in Merck in 2016 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 713 increasing their positions, 710 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 59

30% more funds holding in top 10

Funds holding in top 10: 106138 (+32)

11% more capital invested

Capital invested by funds: $107B → $119B (+$11.6B)

1% more funds holding

Funds holding: 1,7451,762 (+17)

0% more repeat investments, than reductions

Existing positions increased: 713 | Existing positions reduced: 710

0.6% less ownership

Funds ownership: 78.67%78.07% (-0.6%)

14% less call options, than puts

Call options by funds: $1.02B | Put options by funds: $1.18B

Holders
1,762
Holders Change
+17
Holders Change %
+0.97%
% of All Funds
47%
Holding in Top 10
138
Holding in Top 10 Change
+32
Holding in Top 10 Change %
+30.19%
% of All Funds
3.68%
New
92
Increased
713
Reduced
710
Closed
59
Calls
$1.02B
Puts
$1.18B
Net Calls
-$163M
Net Calls Change
-$87M
Name Holding Trade Value Shares
Change
Change in
Stake
TBNY
1226
Trustco Bank (New York)
New York
$880K -$30.7K -576 -3%
BP
1227
Ballentine Partners
Massachusetts
$877K +$19.3K +363 +2%
BCA
1228
Benchmark Capital Advisors
New York
$873K -$329K -6,178 -28%
CL
1229
Choreo LLC
Illinois
$872K +$153K +2,876 +22%
TCM
1230
Telos Capital Management
California
$871K +$43.3K +814 +5%
HCM
1231
Highbridge Capital Management
New York
$870K -$66.4K -1,248 -7%
FFC
1232
First Financial Corp
Indiana
$867K -$423K -7,955 -34%
BWM
1233
BerganKDV Wealth Management
Minnesota
$867K -$62.7K -1,179 -7%
HC
1234
Hourglass Capital
Texas
$867K
BC
1235
Birchview Capital
Vermont
$864K
BAAM
1236
Baker Avenue Asset Management
California
$859K +$39.5K +743 +5%
SCG
1237
Sonata Capital Group
Washington
$858K -$33.4K -628 -4%
CAL
1238
Capital Analysts LLC
Pennsylvania
$853K +$4.84K +91 +0.6%
AWM
1239
Altavista Wealth Management
North Carolina
$853K -$103K -1,936 -11%
WCBA
1240
Weaver C. Barksdale & Associates
Tennessee
$853K
PAM
1241
Princeton Alpha Management
New Jersey
$849K +$822K +15,443 New
DWM
1242
Dorchester Wealth Management
Quebec, Canada
$848K +$35.1K +660 +4%
TPWA
1243
TRUE Private Wealth Advisors
Oregon
$846K +$2.71K +51 +0.3%
KA
1244
KLCM Advisors
Wisconsin
$842K +$112K +2,096 +16%
AUB
1245
Atlantic Union Bankshares
Virginia
$842K +$139K +2,612 +21%
YIA
1246
YHB Investment Advisors
Connecticut
$842K +$360K +6,770 +79%
OCG
1247
Opus Capital Group
Ohio
$841K
SWM
1248
Segment Wealth Management
Texas
$839K -$186K -3,486 -19%
JIC
1249
Joel Isaacson & Co
New York
$838K -$129K -2,418 -14%
FMW
1250
Farr Miller & Washington
District of Columbia
$829K +$150K +2,822 +23%

MRK Hedge Fund Activity: Q2 2016 in Review

1,762 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2016, worth a combined $119B — up 11% from $107B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new MRK positions and 59 closed out — a net gain of 33 holders — while 713 added to existing stakes and 710 trimmed.

The largest buyer was Macquarie Group, adding an estimated $718M. The largest seller was Royal London Asset Management, cutting an estimated $1.98B.

  • 1,762 institutional investors held Merck (MRK) as of Q2 2016, up from 1,745 in Q1 2016.
  • Funds reported $119B of Merck stock for Q2 2016, up 11% quarter-over-quarter.
  • 92 funds opened new Merck positions in Q2 2016 and 59 closed out, a net change of +33 holders.
  • The largest Merck buyer in Q2 2016 was Macquarie Group, an estimated $718M added.
  • The largest Merck seller in Q2 2016 was Royal London Asset Management, an estimated $1.98B sold.

Based on aggregated 13F filings for Q2 2016.